The TI has come under attack in recent years for daring to stand up not only to the pharmaceutical industry, but to the whole system that is failing to protect the public. The system is...
A hard-hitting editorial published in today's BMJ by Fiona Godlee, BMJ Editor in chief, raises the call for clinical trial data for all drugs in current use to be made available for independent scrutiny.
The article begins with...